Stephanie Lerner
Nurse Practitioner · West Palm Beach, FLNPI 1619612157
Payments from drug & device makers
Across 226 payments — averaging $23.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Inogen, Inc.$882
- Boehringer Ingelheim$737
- GSK$610
- Actelion Pharmaceuticals US, Inc.$328
- Regeneron Healthcare Solutions, Inc.$264
- plus $1K from 18 others
What the payments were for
- Food & beverage$5,03395%
- Education$2625%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 47 | $1,226 |
| Inogen, Inc. | 50 | $882 |
| Boehringer Ingelheim | 25 | $737 |
| GSK | 31 | $610 |
| Actelion Pharmaceuticals US, Inc. | 11 | $328 |
| Regeneron Healthcare Solutions, Inc. | 8 | $264 |
| Amgen | 9 | $203 |
| Mylan Specialty L.p. | 8 | $169 |
| United Therapeutics Corporation | 5 | $119 |
| Insmed, Inc. | 5 | $113 |
| Johnson & Johnson | 5 | $91 |
| Sanofi-aventis U.S. LLC | 1 | $85 |
| Verona Pharma, Inc. | 4 | $84 |
| Covis Pharma GmbH | 3 | $82 |
| Merck | 3 | $61 |
| ANI Pharmaceuticals, Inc. | 2 | $47 |
| Paratek Pharmaceuticals, Inc. | 2 | $37 |
| Pulmonx Corporation | 1 | $30 |
| Philips North America LLC | 1 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Bayer | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Vapotherm Inc | 1 | $19 |
| Sanofi | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$245
How this compares
$5,294 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 55 | $770,950 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 350 | $369,657 |
| UptraviSelexipag | 13 | $281,964 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 139 | $131,128 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 60 | $55,733 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 66 | $50,738 |
| Breo ElliptaFluticasone/Vilanterol | 77 | $48,845 |
| SymbicortBudesonide/Formoterol Fumarate | 62 | $25,398 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 23 | $22,738 |
| Spiriva RespimatTiotropium Bromide | 23 | $20,851 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 16 | $10,538 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 289 | $9,954 |
| Incruse ElliptaUmeclidinium Bromide | 15 | $7,800 |
| Ipratropium Bromide | 238 | $7,323 |
| Arnuity ElliptaFluticasone Furoate | 15 | $5,656 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Stiolto Respimat, Combivent Respimat, Spiriva Respimat | $737 | $870,272161 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta, Arnuity Ellipta | $610 | $482,697523 claims |
| Actelion Pharmaceuticals US, Inc.Uptravi | $328 | $281,96413 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $1,226 | $167,064217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in West Palm Beach
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.